Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State
about
The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience.Haematopoietic stem cell transplantation for primary immunodeficiency syndromes: A 5-year single-centre experience.Cost and Cost-Effectiveness Assessments of Newborn Screening for Critical Congenital Heart Disease Using Pulse Oximetry: A Review.Latin American challenges with the diagnosis and treatment of primary immunodeficiency diseases.
P2860
Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cost-Effectiveness/Cost-Benefi ...... Deficiency in Washington State
@en
type
label
Cost-Effectiveness/Cost-Benefi ...... Deficiency in Washington State
@en
prefLabel
Cost-Effectiveness/Cost-Benefi ...... Deficiency in Washington State
@en
P2093
P2860
P1476
Cost-Effectiveness/Cost-Benefi ...... Deficiency in Washington State
@en
P2093
Guisou Zarbalian
Jelili Ojodu
John D Thompson
Lisa Kobrynski
P2860
P304
P356
10.1016/J.JPEDS.2016.01.029
P407
P577
2016-02-11T00:00:00Z